High-Quality Cancer Care in Older Adults
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".
Deadline for manuscript submissions: 1 August 2025 | Viewed by 1862
Special Issue Editors
2. Director Geriatrics Unit, Intermediate Care Hospital, Venerabile Confraternita di Misericordia, via Cammeo 24, Navacchio, 56021 Pisa, Italy
Interests: thyroid cancers; aging process; geriatrics; thyroid function and the aging process; immune- and target therapy
Special Issues, Collections and Topics in MDPI journals
Interests: Alzheimer disease and dementia; cancer in the elderly; target therapy; frailty; the aging process
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The number of cancer diagnoses has been increasing in recent decades as a result of improved diagnostic capacities and demographic modifications. More than half of the subjects who are newly diagnosed with cancer are today aged 65 years or older. These estimates are expected to increase in future decades across high-income countries. As observed for other acute and chronic diseases, cancer treatment in older adults faces two major issues: the low rate of older persons enrolled in randomized clinical trials (the so-called 'evidence-based medicine issue' of geriatrics) and the need to tailor interventions for an heterogeneous population that, due to comorbidity and frailty, may differ from the standard adult population in terms of priorities, preferences and clinically relevant outcomes. Consequently, an evidence-based approach to older cancer patients is still hardly achieved in most cases. In addition, the peculiar characteristics of older patients with cancer can easily lead to either under- or overtreatment, with potentially serious drawbacks for the patients and their caregivers. Indeed, along with the overall decline in cancer-related mortality due to advances in early cancer detection and anticancer treatment, the importance of cancer therapy side effects has increased, especially among older patients. The numerous drawbacks of anticancer treatment include kidney, liver, respiratory and cardiovascular toxicity and dysfunction, especially in frail patients, and should always be taken into account while establishing cancer treatment strategies. Thus, optimizing the management of cancer in older adults represents a major clinical problem and a top priority for modern healthcare systems. The aim of the present Special Issue of Cancers is to sum up the best of scientific knowledge regarding the clinical management and outcome of older patients with cancer, which extends beyond traditional paradigms and implies the assessment of a clinical complexity spanning multiple domains (including physical, cognitive, psychological, affective, socio-economic and environmental aspects). Unpublished research studies as well as reviews and meta-analyses dealing with the peculiar clinical aspects of cancer in older, frail people would, therefore, be much appreciated.
Prof. Dr. Fabio Monzani
Dr. Valeria Calsolaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- elderly
- target therapy
- cancer treatment
- cancer care
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
